Literature DB >> 12898593

Quantitative analysis of colorectal tissue microarrays by immunofluorescence and in situ hybridization.

A M Jubb1, T H Landon, J Burwick, T Q Pham, G D Frantz, B Cairns, P Quirke, F V Peale, K J Hillan.   

Abstract

The accuracy and reliability of in situ studies may be compromised by qualitative interpretations. Quantitation imposes a greater degree of objectivity, is more reproducible, and facilitates the clarity of definitions. The aim of this study was to validate the utility of laser imaging systems for the in situ quantitative analysis of gene expression in tissue microarrays. Immunofluorescence was employed to quantify the expression of the tumour suppressor p53, a marker of proliferation (Ki67), an endothelial cell marker (CD31), and the mismatch repair proteins human Mut L homologue 1 and human Mut S homologue 2 in an arrayed series of colorectal tissues (n = 110). Quantitative data on this panel of antigens were compared objectively with qualitative scoring of immunohistochemical chromogen deposition. In addition, the expression of vascular endothelial growth factor (VEGF)-A, placental growth factor, hepatocyte growth factor, and c-Met mRNA was quantified by phosphor image analysis of in situ hybridization reactions. The quantified data on p53, Ki67, and CD31 expression were significantly associated with the pathologist's score (p < or = 0.001). While hepatocyte growth factor and placental growth factor were not up-regulated, c-Met expression was increased up to 2.5-fold and the median VEGF-A expression was elevated 4-fold (p = 0.003) in this series of colorectal tumours. Laser imaging systems are therefore feasible for high-throughput, quantitative profiling of tissue microarrays. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898593     DOI: 10.1002/path.1371

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  10 in total

Review 1.  Anti-VEGF therapies in the clinic.

Authors:  Kellen L Meadows; Herbert I Hurwitz
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

2.  Application of new tissue microarrayer-ZM-1 without recipient paraffin block.

Authors:  Pan-Qing Meng; Gang Hou; Gui-Ying Zhou; Jia-Ping Peng; Qi Dong; Shu Zheng
Journal:  J Zhejiang Univ Sci B       Date:  2005-09       Impact factor: 3.066

3.  Impact of exploratory biomarkers on the treatment effect of bevacizumab in metastatic breast cancer.

Authors:  Adrian M Jubb; Kathy D Miller; Hope S Rugo; Adrian L Harris; Dafeng Chen; James D Reimann; Melody A Cobleigh; Maike Schmidt; Virginia K Langmuir; Kenneth J Hillan; Daniel S Chen; Hartmut Koeppen
Journal:  Clin Cancer Res       Date:  2011-01-11       Impact factor: 12.531

4.  Use of tissue microarray and automated quantitative analysis for screening and validation of potential biomarkers in mantle cell lymphoma.

Authors:  David T Yang; Philip J Quann; Adam M Petrich; Catherine P Leith; Ken H Young; Brad S Kahl
Journal:  Appl Immunohistochem Mol Morphol       Date:  2011-01

5.  Fluorescent Immunohistochemistry.

Authors:  Vanessa Moreno; Elizabeth A Smith; Sergio Piña-Oviedo
Journal:  Methods Mol Biol       Date:  2022

6.  Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.

Authors:  A M Jubb; T Q Pham; A M Hanby; G D Frantz; F V Peale; T D Wu; H W Koeppen; K J Hillan
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

7.  Transcriptome sequencing of the blind subterranean mole rat, Spalax galili: utility and potential for the discovery of novel evolutionary patterns.

Authors:  Assaf Malik; Abraham Korol; Sariel Hübner; Alvaro G Hernandez; Jyothi Thimmapuram; Shahjahan Ali; Fabian Glaser; Arnon Paz; Aaron Avivi; Mark Band
Journal:  PLoS One       Date:  2011-08-12       Impact factor: 3.240

8.  Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer.

Authors:  A M Jubb; H Turley; H C Moeller; G Steers; C Han; J-L Li; R Leek; E Y Tan; B Singh; N J Mortensen; I Noguera-Troise; F Pezzella; K C Gatter; G Thurston; S B Fox; A L Harris
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

Review 9.  Anti-angiogenic strategies in gastrointestinal malignancies.

Authors:  Jonathan Whisenant; Emily Bergsland
Journal:  Curr Treat Options Oncol       Date:  2005-09

10.  TAMEE: data management and analysis for tissue microarrays.

Authors:  Gerhard G Thallinger; Kerstin Baumgartner; Martin Pirklbauer; Martina Uray; Elke Pauritsch; Gabor Mehes; Charles R Buck; Kurt Zatloukal; Zlatko Trajanoski
Journal:  BMC Bioinformatics       Date:  2007-03-07       Impact factor: 3.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.